Introduction. - This study was aimed at reviewing useful criteria for the d
iagnosis of fever of paraneoplastic origin in patients with cancer.
Current knowledge and key points. - Apart from episodes of neutropenia, hyp
erthermia is observed in approximately 60% of patients with cancer. Fever i
s often due to infection and, as a contraindication, may hamper treatment T
he differential diagnosis, ie., fever of paraneoplastic or infectious origi
n, may be difficult Paraneoplastic fever is mostly observed in patients wit
h advanced cancel: It is related to the production of inflammatory cytokine
s, especially interleukin 6 and is not specific. Neither current markers of
inflammation, nor X-ray: nor naproxen confirm diagnosis. The diagnosis of
fever of paraneoplastic origin in patients with cancer should rely on a net
work of arguments to exclude other causes of fever, especially infectious c
auses.
Future and projects. - Further evaluation of the specificity of procalciton
in will determine whether or not it is a useful tool for the diagnosis of f
ever of paraneoplastic or infectious origin. (C) 2000 Editions scientifique
s et medicales Elsevier SAS.